The TWiV team reviews the first FDA approved gene therapy, accidental exposure to poliovirus type 2 in a manufacturing plant, and production of a candidate poliovirus vaccine in plants.

Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler

Become a patron of TWiV!

Links for this episode

ASM Conference on Viral Manipulation of Nuclear Processes
ASM Public Outreach Fellowship
Kymriah approved (PennMed)
CAR T cells (NCBI)
Cost of Kymriah (NYTimes)
Accidental exposure to poliovirus type 2 (Eurosurveill)
GAPIII (WHO)
Poliovaccine candidate in plants (Nat Commun)
Vertical vaccine farm (TWiV 47)
All picornaviruses, all the time (TWiV 425)
Image credit
Letters read on TWiV 459

This episode is brought to you by the Defense Threat Reduction Agency. Part of the U.S. Department of Defense, the Agency's Chemical and Biological Technologies Department hosts the 2017 Chemical and Biological Defense Science & Technology Conference to exchange information on the latest and most dynamic developments for countering chemical and biological weapons of mass destruction. Find out more at http://www.cbdstconference.com

Weekly Science Picks

Kathy - Cassini photos Dickson - Caliber Biotherapeutics Alan - Grav Rich - Google street view of the International Space Station (article) Vincent - the bioinformatics chat

Intro music is by Ronald Jenkees.

Send your virology questions and comments to twiv@microbe.tv

The Deep Dive - Episode Three: Moshiri’s first 60 days